Key Market Insights
 Presently, around 80 well-established players across the globe claim to offer DNA and gene cloning associated services; a relatively larger proportion of these players are small companies based in North America
 Leveraging their expertise, service providers offer different DNA and gene cloning services for a variety of genes; further, majority of the players offer custom cloning services
 In pursuit of building a competitive edge, stakeholders in this domain are striving to enhance their service portfolio and upgrade their DNA and gene cloning related services
 More than 1,350 patents related to DNA and gene cloning have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field
 Over the past few years, several articles focused on DNA cloning and gene cloning have been published by eminent authors in various high-impact journals; Methods in Molecular Biology emerged as the popular journal
 The growing interest in the field of DNA and gene cloning is also reflected by the events organized to provide an opportunity to several stakeholders to share their ideas and develop a better understanding of such processes
 With the rising demand for DNA and gene cloning services, the market is expected to grow at an annualized rate of 16% between 2022-2035
 The current and projected future market opportunity is likely to be well distributed across various company sizes, end users and key geographies


Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentations
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to DNA Cloning
3.3. Methods of DNA Cloning
3.3.1. Restriction Enzyme Based Cloning
3.3.2. PCR Cloning
3.3.3. Ligation Independent Cloning
3.3.4. TA Cloning
3.3.5. Blunt End Cloning
3.3.6. Seamless Cloning
3.3.7. Recombinational Cloning

3.4. Techniques Used in DNA and Gene Cloning
3.4.1. Molecular Cloning
3.4.2. Genetic Synthesis
3.4.3. Custom Cloning

3.5. Types of Genes Cloned
3.5.2. Standard Genes
3.5.3. Complex Genes

3.6. Type of Expression Systems Used in DNA and Gene Cloning
3.6.1. Mammalian Expression System
3.6.2. Insect Expression System
3.6.3. Bacterial Expression System
3.6.4. Plant Expression System
3.6.5. Yeast Expression System

3.7. Cloning Vectors
3.7.1. Plasmids
3.7.2. Bacteriophages
3.7.3. Bacterial Artificial Chromosomes (BACs)
3.7.4. Yeast Artificial Chromosomes (YACs)
3.7.5. Mammalian Artificial Chromosomes (MACs)

3.8. Applications of DNA and Gene Cloning
3.9. Challenges associated with DNA and Gene Cloning
3.10. Outsourcing of DNA and Gene Cloning Services
3.11. Future Perspectives

4. MARKET LANDSCAPE: DNA AND GENE CLONING SERVICE PROVIDERS
4.1. Chapter Overview
4.2. DNA and Gene Cloning Service Providers Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Region of Headquarters
4.2.4. Analysis by Company Size and Region of Headquarters

4.3. DNA and Gene Cloning Services: Overall Market Landscape
4.3.1. Analysis by Type of Service(s) Offered
4.3.2. Analysis by Cloning Method(s) Used
4.3.3. Analysis by Type of Gene(s) Cloned
4.3.4. Analysis by Expression System(s) Used
4.3.5. Analysis by Cloning Vector(s) Used
4.3.6. Analysis by End User

5. BENCHMARK ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Benchmark Analysis: Peer Groups
5.4.1. Benchmark Analysis: North America (Peer Group I)
5.4.2. Benchmark Analysis: North America (Peer Group II)
5.4.3. Benchmark Analysis: North America (Peer Group III)
5.4.4. Benchmark Analysis: Europe (Peer Group IV)
5.4.5. Benchmark Analysis: Europe (Peer Group V)
5.4.6. Benchmark Analysis: Asia-Pacific and Rest of the World (Peer Group VI)
5.4.7. Benchmark Analysis: Asia-Pacific and Rest of the World (Peer Group VII)

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Aragen Life Sciences
6.2.1. Company Overview
6.2.2. Service Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Bio-Techne
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Service Portfolio
6.3.4. Recent Developments and Future Outlook

6.4. Charles River Laboratories
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Service Portfolio
6.4.4. Recent Developments and Future Outlook

6.5. Curia
6.5.1. Company Overview
6.5.2. Service Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. Eurofins
6.6.1. Company Overview
6.6.2. Financial Information
6.6.3. Service Portfolio
6.6.4. Recent Developments and Future Outlook

6.7. GenScript
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Service Portfolio
6.7.4. Recent Developments and Future Outlook

6.8. Integrated DNA Technologies
6.8.1. Company Overview
6.8.2. Service Portfolio
6.8.3. Recent Developments and Future outlook

6.9. MedGenome
6.9.1. Company Overview
6.9.2. Service Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Sino Biological
6.10.1. Company Overview
6.10.2. Service Portfolio
6.10.3. Recent Developments and Future Outlook

6.11. Syngene
6.11.1. Company Overview
6.11.2. Financial Information
6.11.3. Service Portfolio
6.11.4. Recent Developments and Future Outlook

6.12. Twist Bioscience
6.12.1. Company Overview
6.12.2. Financial Information
6.12.3. Service Portfolio
6.12.4. Recent Developments and Future Outlook

7. PATENT ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. DNA and Gene Cloning: Patent Analysis
7.3.1. Analysis by Publication Year
7.3.2. Analysis by Application Year
7.3.3. Analysis by Annual Number of Granted Patents and Patent Applications
7.3.4. Analysis by Geographical Location
7.3.5. Analysis by CPC Symbols
7.3.6. Analysis by Focus Area
7.3.7. Analysis by Type of Applicant
7.3.8. Leading Players: Analysis by Number of Patents
7.3.9. Leading Individual Assignees: Analysis by Number of Patents

7.4. DNA and Gene Cloning: Patent Benchmarking Analysis
7.4.1. Analysis by Patent Characteristics
7.5. DNA and Gene Cloning: Patent Valuation Analysis
7.6. Leading Patents by Number of Citations

8. PUBLICATION ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.2.1. Analysis by Year of Publication
8.2.2. Analysis by Type of Cloning
8.2.3. Word Cloud: Emerging Focus Areas
8.2.4. Popular Journals: Analysis by Number of Publications
8.2.5. Leading Authors: Analysis by Number of Publications
8.2.6. Leading First Authors: Analysis by Number of Publications

9. GLOBAL EVENT ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. List of Global Events related to DNA and Gene Cloning
9.3.1. Analysis by Year of Event
9.3.2. Analysis by Event Platform
9.3.3. Analysis by Type of Event
9.3.4. Analysis by Geography
9.3.5. Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Area
9.3.6. Most Active Participants: Analysis by Number of Events
9.3.7. Analysis by Seniority Level of Event Speakers
9.3.8. Geographical Mapping of Upcoming Events

10. MARKET FORECAST
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions

10.3. Global DNA and Gene Cloning Services Market, 2022-2035
10.3.1. DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Services Offered
10.3.1.1. DNA and Gene Cloning Services Market for Gene Synthesis, 2022-2035
10.3.1.2. DNA and Gene Cloning Services Market for Custom Cloning, 2022-2035
10.3.1.3. DNA and Gene Cloning Services Market for Sub-cloning, 2022-2035
10.3.1.4. DNA and Gene Cloning Services Market for Other Services, 2022-2035

10.3.2. DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Type of
Genes Cloned
10.3.2.1. DNA and Gene Cloning Services Market for Standard Gene, 2022-2035
10.3.2.2. DNA and Gene Cloning Services Market for Complex Gene, 2022-2035
10.3.2.3. DNA and Gene Cloning Services Market for Other Genes, 2022-2035

10.3.3. DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Company Size
10.3.3.1. DNA and Gene Cloning Services Market for Small Companies, 2022-2035
10.3.3.2. DNA and Gene Cloning Services Market for Mid-sized Companies, 2022-2035
10.3.3.3. DNA and Gene Cloning Services Market for Large Companies, 2022-2035

10.3.4. DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by End User Industry
10.3.4.1. DNA and Gene Cloning Services Market for Academic and R&D, 2022-2035
10.3.4.2. DNA and Gene Cloning Services Market for Pharmaceutical and Biotechnology Companies, 2022-2035
10.3.4.3. DNA and Gene Cloning Services Market for Other End Users, 2022-2035
10.3.5. DNA and Gene Cloning Services Market, 2022 and 2035: Distribution by Key
Geographical Regions
10.3.5.1. DNA and Gene Cloning Services Market in North America, 2022-2035
10.3.5.2. DNA and Gene Cloning Services Market in Europe, 2022-2035
10.3.5.3. DNA and Gene Cloning Services Market in Asia-Pacific, 2022-2035
10.3.5.4. DNA and Gene Cloning Services Market in Latin America, 2022-2035
10.3.5.5. DNA and Gene Cloning Services Market in MENA, 2022-2035

11. CASE STUDY: DNA AND GENE CLONING KITS AND REAGENTS
11.1. Chapter Overview
11.2. DNA Cloning Kits
11.2.1. Analysis by Kit Components
11.2.2. Analysis by Number of Reactions
11.2.3. Analysis by Type of Cloning Method Used
11.2.4. Analysis by Type of Fragment Cloned
11.2.5. Analysis by Cloning Time
11.2.6. Analysis by Efficacy
11.2.7. Analysis by Kit Shelf Life

11.3. DNA Cloning Reagents
11.3.1. Analysis by Unit Size
11.3.2. Analysis by Reagent Concentration
11.3.3. Analysis by Reagent Components
11.3.4. Analysis by Exonuclease Activity
11.3.5. Analysis by Product Overhangs
11.3.6. Analysis by Heat Inactivation Temperature
11.3.7. Analysis by Storage Temperature

11.4. Players in North America
11.4.1. DNA Cloning Kit Developers
11.4.2. DNA Cloning Reagent Developers
11.4.3. DNA Cloning Service Providers

11.5. Players in Europe
11.5.1. DNA Cloning Kit Developers
11.5.2. DNA Cloning Reagent Developers
11.5.3. DNA Cloning Service Providers

11.6. Players in Asia-Pacific and Rest of the World
11.6.1. DNA Cloning Kit Developers
11.6.2. DNA Cloning Reagent Developers
11.6.3. DNA Cloning Service Providers

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Get more details on the DNA and Gene Cloning Services Market report https://www.rootsanalysis.com/reports/dna-and-gene-cloning-market.html

Learn from experts: do you know about these emerging industry trends?
Cannabis Testing / Hemp Testing: Unlocking the Future Opportunities in Healthcare
The Future Of Healthcare: Wearable Injectors Unveiled
Top 5 Companies Developing Tangential Flow Filtration Systems Used in Biologics Industry

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:
Ben Johnson
+1 (415) 800 3415
[email protected]